Press Releases

Australia’s largest and most successful biotechnology company, CSL, will officially celebrate 100 years of operation on 25th April 2016. World pharma today/Press releases /-Originally named the ‘Commonwealth Serum Laboratories’, CSL was established in 1916 by the...

AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. The initiative includes new collaborations with Human...

CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC. The four-in-one event will take place at the Istanbul Congress Center (ICC).   Turkey, from...

Novo Nordisk announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. The expansions will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines. ...

Baxter International Inc announced it has received Marketing Authorization from the Competent Authorities in the United Kingdom and Denmark for NUMETA G13E 300 mL, a parenteral (intravenous) nutrition (PN) product. These national approvals are the first of 20 European...

Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated World pharma today/Press releases /-Eisai Co Ltd. announced that it has presented the results of non-clinical research investigating the combination of Eisai's in-house...

Merck known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of patients with relapsed...